Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RIMEGEPANT SULFATE, with a corresponding US DMF Number 38715.
Remarkably, this DMF maintains an Active status since its submission on September 28, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 13, 2023, and payment made on August 14, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II